Cours ZIVO Bioscience, Inc. Other OTC
Actions
ZIVO
US98978N1019
Transformation des aliments
CA 2024 * | 545 k 494 k | CA 2025 * | 1,51 M 1,37 M | Capitalisation | 21,95 M 19,88 M |
---|---|---|---|---|---|
Résultat net 2024 * | -8 M -7,25 M | Résultat net 2025 * | -8 M -7,25 M | VE / CA 2024 * | 40,3 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 14,6 x |
PER 2024 * |
-2,84
x | PER 2025 * |
-3,56
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 59,23% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
John Payne
CEO | Chief Executive Officer | 76 | 19/07/13 |
Keith Marchiando
DFI | Director of Finance/CFO | 61 | 01/01/21 |
Laura Belicka
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/21 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 77 | 17/09/14 | |
Director/Board Member | 58 | 28/08/13 | |
John Payne
CEO | Chief Executive Officer | 76 | 19/07/13 |
Varia. 1 janv. | Capi. | |
---|---|---|
+16,80% | 8,43 Md | |
+15,02% | 6,82 Md | |
-4,77% | 3,77 Md | |
-6,75% | 3,74 Md | |
+4,41% | 1,44 Md | |
-30,34% | 1,06 Md | |
+20,28% | 1,04 Md | |
-12,85% | 890 M | |
-15,63% | 812 M |